Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 7NIH 5NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Teratoma 1Choriocarcinoma 1Carcinoma, Embryonal 1

Interventions

Specimen Handling 48Magnetic Resonance Spectroscopy 39Cyclophosphamide 29Vincristine 23Radiation 20Dexamethasone 19Radiotherapy 18Etoposide 18Cisplatin 18Biopsy 18Carboplatin 17Doxorubicin 13Cytarabine 13daratumumab 12Leucovorin 12Methotrexate 11Gemcitabine 11X-Rays 10Standard of Care 10Radiotherapy, Intensity-Modulated 10Platinum 10Docetaxel 10durvalumab 9Rituximab 9Radiotherapy, Conformal 9Prednisone 9Practice Guidelines as Topic 9Calcium Dobesilate 91,2-diaminocyclohexaneplatinum II citrate 9merphos 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × pegylated granulocyte colony-stimulating factor × 90 days × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡